Luyan Pharma Co.,Ltd. (002788.SZ)
002788.SZ Stock Price Chart
Explore Luyan Pharma Co.,Ltd. interactive price chart. Choose custom timeframes to analyze 002788.SZ price movements and trends.
002788.SZ Company Profile
Discover essential business fundamentals and corporate details for Luyan Pharma Co.,Ltd. (002788.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
IPO Date
18 Feb 2016
Employees
5.60K
Website
https://www.luyan.com.cnCEO
Jinxiang Wu
Description
Luyan Pharma Co.,Ltd. engages in the research and development, production, and sale of human health products in China. It also operates pharmaceutical distribution and retail direct stores. The company was formerly known as Luyan (Fujian) Pharma Co. Ltd. and changed its name to Luyan Pharma Co.,Ltd. in June 2016. Luyan Pharma Co.,Ltd. was founded in 1992 and is headquartered in Xiamen, China.
002788.SZ Financial Timeline
Browse a chronological timeline of Luyan Pharma Co.,Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 10 Jul 2025
A dividend of ¥0.35 per share was announced, adjusted to ¥0.35. The dividend was paid on 10 Jul 2025.
Earnings released on 7 May 2025
EPS came in at ¥0.23 , while revenue for the quarter reached ¥5.06B .
Earnings released on 31 Mar 2025
Revenue for the quarter reached ¥5.17B .
Earnings released on 29 Sept 2024
EPS came in at ¥0.17 , while revenue for the quarter reached ¥5.11B .
Dividend declared on 4 Jul 2024
A dividend of ¥0.30 per share was announced, adjusted to ¥0.30. The dividend was paid on 4 Jul 2024.
Earnings released on 29 Jun 2024
EPS came in at ¥0.27 , while revenue for the quarter reached ¥5.16B .
Earnings released on 7 May 2024
EPS came in at ¥0.26 , while revenue for the quarter reached ¥5.07B .
Earnings released on 31 Mar 2024
EPS came in at ¥0.22 , while revenue for the quarter reached ¥5.14B .
Earnings released on 30 Sept 2023
EPS came in at ¥0.19 , while revenue for the quarter reached ¥4.75B .
Earnings released on 30 Jun 2023
EPS came in at ¥0.28 , while revenue for the quarter reached ¥5.18B .
Dividend declared on 14 Jun 2023
A dividend of ¥0.30 per share was announced, adjusted to ¥0.30. The dividend was paid on 14 Jun 2023.
Earnings released on 31 Mar 2023
EPS came in at ¥0.21 , while revenue for the quarter reached ¥4.84B .
Earnings released on 1 Jan 2023
EPS came in at ¥0.24 , while revenue for the quarter reached ¥5.14B .
Earnings released on 30 Sept 2022
EPS came in at ¥0.21 , while revenue for the quarter reached ¥4.98B .
Dividend declared on 6 Jul 2022
A dividend of ¥0.30 per share was announced, adjusted to ¥0.30. The dividend was paid on 6 Jul 2022.
Earnings released on 30 Jun 2022
EPS came in at ¥0.24 , while revenue for the quarter reached ¥4.70B .
Earnings released on 31 Mar 2022
EPS came in at ¥0.18 , while revenue for the quarter reached ¥4.64B .
Earnings released on 31 Dec 2021
EPS came in at ¥0.20 , while revenue for the quarter reached ¥4.54B .
Earnings released on 30 Sept 2021
EPS came in at ¥0.20 , while revenue for the quarter reached ¥4.53B .
Earnings released on 30 Jun 2021
EPS came in at ¥0.23 , while revenue for the quarter reached ¥4.31B .
Dividend declared on 3 Jun 2021
A dividend of ¥0.20 per share was announced, adjusted to ¥0.20. The dividend was paid on 3 Jun 2021.
Earnings released on 28 Apr 2021
EPS came in at ¥0.17 , while revenue for the quarter reached ¥4.13B .
Earnings released on 31 Mar 2021
EPS came in at ¥0.17 , while revenue for the quarter reached ¥4.17B .
Earnings released on 30 Sept 2020
EPS came in at ¥0.25 , while revenue for the quarter reached ¥4.19B .
Stock split effective on 17 Sept 2020
Shares were split 1073 : 1000 , changing the number of shares outstanding and the price per share accordingly.
002788.SZ Stock Performance
Access detailed 002788.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.